We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-19.74%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$275M
AUM Growth
-$16.9M
Cap. Flow
+$40.9M
Cap. Flow %
14.91%
Top 10 Hldgs %
36.4%
Holding
93
New
30
Increased
20
Reduced
14
Closed
25

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$11.5M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$11M
3
CVS icon
CVS Health
CVS
+$10.8M
4
MDT icon
Medtronic
MDT
+$8.96M
5
CAH icon
Cardinal Health
CAH
+$7.66M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$14.6M
2
AET
Aetna Inc
AET
+$12.3M
3
KURA icon
Kura Oncology
KURA
+$7.72M
4
BIIB icon
Biogen
BIIB
+$6.82M
5
ELV icon
Elevance Health
ELV
+$6.8M

Sector Composition

Rank Sector Weight
1 Healthcare 91.02%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
76
GSK
GSK
$104B
– –
-291,168
Closed -$14.6M
IMUX icon
77
Immunic
IMUX
$190M
– –
-259
Closed -$29K
IMUX icon
78
PUT
Immunic
IMUX
$190M
– –
-487
Closed -$54K
MRK icon
79
CALL
Merck
MRK
$322B
– –
-88,032
Closed -$5.96M
NVS icon
80
Novartis
NVS
$297B
– –
-64,383
Closed -$4.97M
OPTN
81
DELISTED
OptiNose
OPTN
– –
-1,805
Closed -$336K
PBYI icon
82
Puma Biotechnology
PBYI
$404M
– –
-32,832
Closed -$1.5M
PCRX icon
83
PUT
Pacira BioSciences
PCRX
$1.04B
– –
-281,100
Closed -$13.8M
PFE icon
84
PUT
Pfizer
PFE
$143B
– –
-75,361
Closed -$3.15M
UHS icon
85
Universal Health Services
UHS
$10.2B
– –
-41,393
Closed -$5.29M
XRAY icon
86
PUT
Dentsply Sirona
XRAY
$2.68B
– –
-170,000
Closed -$6.42M
NVRO
87
DELISTED
NEVRO CORP.
NVRO
– –
-45,091
Closed -$2.57M
ONCT
88
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-368
Closed -$81K
SPPI
89
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-70,712
Closed -$1.19M
AMAG
90
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-226,200
Closed -$4.52M
AKCA
91
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
– –
-43,300
Closed -$1.52M
AGN
92
PUT
DELISTED
Allergan plc
AGN
– –
-17,500
Closed -$3.33M
AET
93
DELISTED
Aetna Inc
AET
– –
-60,444
Closed -$12.3M
1 2 3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sio Capital Management held 93 positions worth $275M, down 5.8% from $291M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sio Capital Management deployed $40.9M of net new capital in Q4 2018, opening 30 new positions and adding to 20 existing holdings. Its largest new stake was Cencora: 133,934 shares worth $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 75% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Kura Oncology, an estimated $7.72M trimmed.

  • Sio Capital Management's largest Q4 2018 buy was Cencora: 133,934 shares worth $9.96M.
  • Sio Capital Management added most to Medtronic in Q4 2018, an estimated $8.96M increase.
  • Sio Capital Management's biggest Q4 2018 reduction was Kura Oncology, cutting an estimated $7.72M.
  • Sio Capital Management fully exited GSK in Q4 2018, selling an estimated $14.6M.
  • Sio Capital Management's ten largest holdings make up 36% of its $275M portfolio in Q4 2018.
  • Sio Capital Management opened 30 new positions and closed 25 in Q4 2018.
  • Sio Capital Management's portfolio value fell 5.8% quarter-over-quarter to $275M.

Based on Sio Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.